pharmaceuticals

Global Custom Market Research Reports Provider Company

phone

Autonomous University of Barcelona - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 18
  • Category: Pharmaceuticals
  • Country: Spain
Summary

Autonomous University of Barcelona (UAB) is a public research institute that provides undergraduate, post graduate, masters, doctorates, and foreign undergraduate programs. The institute offers educational programs in various streams such as arts and science; economics and medicine through its research centers and teaching centers. It has various departments in the field of health sciences and technology sciences; social sciences and humanities. The institute also offers research activities in the fields of health sciences such as animal and food science; medicine, pharmacology, animal health and anatomy; experimental and technological sciences and social sciences. UAB is headquartered in Bellaterra, Barcelona, Spain.

Autonomous University of Barcelona - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autonomous University of Barcelona, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
R-Tech Ueno Plans to Enter into Research Agreement with UAB and VHIR 10
Licensing Agreements 11
Kogenix Therapeutics Enters into Licensing Agreement with University of Barcelona and Vall dHebron Research 11
Janus Developments Enters Into Licensing Agreement With UB, CSIC And UAB 12
Autonomous University of Barcelona - Key Competitors 13
Autonomous University of Barcelona - Key Employees 14
Autonomous University of Barcelona - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Government and Public Interest 16
Feb 28, 2018: RAC1 protein could be a new therapeutic target to fight neurodegeneration in Parkinsons disease 16
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables

List of Tables
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Key Facts 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autonomous University of Barcelona, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autonomous University of Barcelona, Deals By Therapy Area, 2012 to YTD 2018 8
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
R-Tech Ueno Plans to Enter into Research Agreement with UAB and VHIR 10
Kogenix Therapeutics Enters into Licensing Agreement with University of Barcelona and Vall dHebron Research 11
Janus Developments Enters Into Licensing Agreement With UB, CSIC And UAB 12
Autonomous University of Barcelona, Key Competitors 13
Autonomous University of Barcelona, Key Employees 14
Autonomous University of Barcelona, Subsidiaries 15

List Of Figures

List of Figures
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

In this report, the global Autonomous Ships market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing

View Report

In this report, the global Automotive Autonomous Emergency Braking System (AEBS) market is valued at USD XX million in 2017 and is expected to reach USD XX million by the

View Report

In this report, the global Autonomous Vehicle market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports